Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: April 2013

HINJ to Host ‘Chronic Disease Management’ Policy Forum on May 23

New Brunswick, NJ, April 9, 2013 — The HealthCare Institute of New Jersey (HINJ) will host a health policy forum titled “Chronic Disease Management:  Improving Outcomes & Bending the Cost Curve” on Thursday, May 23 at Forsgate Country Club in Monroe Township.

HINJ invites you to join leaders of New Jersey’s healthcare community for a discussion about how better management of chronic disease can improve patient outcomes and lower costs.  Speakers will include: Continue reading

NJBIZ: Universities Say Public, Private Must Partner in Changing Landscape

Somerset, NJ, April 5, 2013NJBIZ’s Melinda Caliendo reports on higher-education institutions, the private sector, the changing innovation-driven business and research landscape and how New Jersey is responding.

Public-private partnerships are just “how the modern university works,” according to Joel Bloom, president of the New Jersey Institute of Technology.

Bloom told Caliendo that NJIT is partnering with private business to get construction projects done, to give entrepreneurs a steady place to start their own empires and to deliver innovative research that can be applied and commercialized.

Recognizing the need to advance corporate and academic partnerships, Caliendo reports that a fourth arm has been added to Lt. Gov. Kim Guadagno’s Partnership for Action:  Rochelle Hendricks, secretary of higher education. Continue reading

President Obama Unveils Human Brain-Mapping Initiative

Washington, DC, April 3, 2013 — President Obama yesterday unveiled a government-sponsored initiative to map the human brain, casting the proposal as a way to discover new cures for neurological disease and strengthen the economy, The Washington Post reported. 

The ambitious project is called the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative.

“Ideas are what power our economy,” President Obama said as he announced the proposal from the East Room of the White House.  “When we invest in the best ideas before anybody else does, our businesses and our workers can make the best products and deliver the best services before anybody else.” Continue reading

Opinion: Time for Safe Solution for Rx Supply Chain

Washington, DC, April 3, 2013Politico has published an opinion piece regarding the safety of the current pharmaceutical supply chain written by John Castellani, president and CEO of PhRMA; John Gray, president and CEO of the Healthcare Distribution Management Association; and Ralph Neas, president and CEO of the Generic Pharmaceutical Association.

“Three times in the past year…,” they write, “the Food and Drug Administration (FDA) has issued warnings that counterfeit cancer drugs originating overseas infiltrated the US pharmaceutical supply chain, putting patients at risk.” 

“Recognizing the severity of this growing threat as a global problem,” they continue, “the Institute of Medicine (IOM) recently released a set of recommendations calling for, among other things, enactment of a national solution capable of enhancing the ability to trace finished pharmaceutical products throughout the vast and complex U.S. distribution chain.” Continue reading

HINJ, NJLSVA and WWFH-NJ Host Congressman Rob Andrews

(l. to r.) NJLSVA Executive Director Don Sico, Rep. Andrews, Dean Paranicas, HINJ’s Steve Issenman

Cherry Hill, NJ, April 2, 2013 — The HealthCare Institute of New Jersey (HINJ), the New Jersey Life Sciences Vendors Alliance (NJLSVA) and We Work For Health-New Jersey (WWFH-NJ) this morning hosted U.S. Representative Rob Andrews (D-1st) at a life sciences vendors breakfast roundtable in Cherry Hill, NJ.

HINJ President and Chief Executive Officer Dean J. Paranicas said, “Concurrent with the growth of life sciences in New Jersey, the most comprehensive and specialized network of industry vendors in the world has evolved here that provides critical support to our industry.”  “Certainly, the Garden State’s life sciences cluster could not grow and prosper without the support that all of you provide,” he added. Continue reading

PhRMA’s Statement on India Supreme Court Decision on Generic Drugs

Washington, DC, April 2, 2013Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement yesterday:

“PhRMA is very disappointed with the Indian Supreme Court’s decision to deny a patent on Glivec.  This decision marks yet another example of the deteriorating innovation environment in India. 

“Innovation is critical in meeting unmet needs of patients and is particularly relevant in the context of changing healthcare systems.  In order to solve the real health challenges of India’s patients, it is critically important that India promote a policy environment that supports continued research and development of new medicines for the health of patients in India and worldwide. Continue reading